Real-life comparison of DPP4-inhibitors
โ
A. Penfornis; I. Bourdel-Marchasson; S. Quere; S. Dejager
๐
Article
๐
2012
๐
Masson Editeur
๐
French
โ 309 KB
## Aim: Despite half of all type 2 diabetes mellitus (t2dm) patients being over 65 and treatment being complicated by an elevated risk of iatrogenic hypoglycaemia, information about antidiabetic treatment is scarce in this age group. this prospective observational study compares dpp4-inhibitors (dp